The kinases PKC-betaI [8] and PRK1a (also termed PKN1) [9] play important roles in activating gene transcription [10] in the course of androgen receptor signalling and PRK1 is considered to be a promising target for the treatment of prostate cancer. Here, PKN1 is linked to prostate carcinoma.